Noel Jean-Christophe, Anaf Vincent, Fayt Isabelle, Wespes Eric
Department of Gynecopathology, Erasme University Hospital, Free University of Brussels, Brussels, Belgium.
Arch Gynecol Obstet. 2006 Oct;274(6):389-92. doi: 10.1007/s00404-006-0188-1. Epub 2006 Jun 8.
Malignant transformation and particularly malignant mixed mullerian tumor arising in extragenital endometriosis is extremely rare and occurs in the majority of cases after estrogen replacement therapy. We present a case of a 75-year-old woman who developed a ureteral malignant mullerian carcinosarcoma in a context of florid endometriosis. The patient had a history of total hysterectomy with bilateral salpingo-oophorectomy 30 years earlier for extensive endometriosis. Since 5 years, the patient has been on phytoestrogen supplementation consisting of 72 mg/day of superconcentrated soy isoflavones. This is the first case of ureteral mullerian carcinosarcoma arising in endometriosis foci after extensive phytoestrogen supplementation. Our data suggest that phytoestrogens at least in concentrated form may play a role not only in maintenance of endometriosis but also in its malignant transformation. Given the extraordinary popularity and availability of these dietary supplements, several studies are indispensable regarding their safety particularly in women with extensive endometriosis.
发生于生殖器外子宫内膜异位症的恶性转化,尤其是恶性混合苗勒管肿瘤极为罕见,且大多数病例发生于雌激素替代治疗之后。我们报告一例75岁女性患者,其在活跃的子宫内膜异位症背景下发生了输尿管恶性苗勒管癌肉瘤。该患者30年前因广泛的子宫内膜异位症接受了全子宫切除术及双侧输卵管卵巢切除术。5年来,患者一直服用植物雌激素补充剂,即每天72毫克的超浓缩大豆异黄酮。这是首例在大量补充植物雌激素后,子宫内膜异位症病灶发生输尿管苗勒管癌肉瘤的病例。我们的数据表明,至少浓缩形式的植物雌激素不仅可能在维持子宫内膜异位症方面起作用,还可能在其恶性转化中起作用。鉴于这些膳食补充剂非常普及且容易获得,关于其安全性,尤其是对患有广泛子宫内膜异位症的女性,进行多项研究是必不可少的。